Status:

COMPLETED

Dronabinol in Total Knee Arthroplasty (TKA)

Lead Sponsor:

Hospital for Special Surgery, New York

Conditions:

Total Knee Arthroplasty

Opioid Use

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The goal of this double-blinded randomized controlled trial is to compare whether the addition of Dronabinol compared to a placebo will affect opioid intake in patients undergoing a total knee arthrop...

Detailed Description

The objective of this study is to examine the possible therapeutic advantages of administering perioperative dronabinol to individuals who are undergoing unilateral total knee arthroplasty (TKA). With...

Eligibility Criteria

Inclusion

  • Patients aged between 18-70 years old with osteoarthrosis scheduled for primary unilateral knee arthroplasty with a participating surgeon
  • Planned use of regional anesthetic technique during surgery involving infiltration between the popliteal artery and the capsule of the posterior knee (IPACK), adductor canal block (ACB) and periarticular injection (PAI)
  • Ability to follow study protocol

Exclusion

  • Patients less than 18 years of age or older than 70 years of age
  • Contraindication to regional or neuraxial anesthetic
  • Intended use of general anesthesia
  • Revision surgery
  • Chronic opioid use (for \>3 months prior to surgery)
  • Cannabis/cannabinoid use within the last 3 months
  • ASA class of IV or greater
  • Active or history of major mental history (as defined by the Diagnostic and Statistical Manual of Mental Disorders-5 \[DSM-5\]; i.e. major depressive disorder, anxiety, bipolar disorder, schizophrenia)
  • History of seizures
  • Use of antidepressants
  • Use of anticonvulsants
  • Use of Coumadin
  • Use of Disulfuram
  • Use of Metronidazole
  • Non-English speakers
  • BMI ≥40

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2024

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT04734080

Start Date

March 1 2021

End Date

April 1 2024

Last Update

January 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital for Special Surgery

New York, New York, United States, 10021